Journal article
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing
Abstract
Risk sharing arrangements relate to adjusting payments for new health technologies given evidence of their performance over time. Such arrangements rely on prospective information regarding the incremental net benefit of the new technology, and its use in practice. However, once the new technology has been adopted in a particular jurisdiction, randomized clinical trials within that jurisdiction are likely to be infeasible and unethical in the …
Authors
Eckermann S; Willan AR
Journal
PharmacoEconomics, Vol. 31, No. 5, pp. 393–401
Publisher
Springer Nature
Publication Date
5 2013
DOI
10.1007/s40273-013-0038-5
ISSN
1170-7690